David Paterson is a Professor of Medicine at the National University of Singapore, where he also directs ADVANCE-ID. This is a clinical trials network comprising more than 100 hospitals across Asia. Professor Paterson’s previous appointments have included Chief of Transplant Infectious Diseases at the University of Pittsburgh Medical Center and Director of the University of Queensland Centre for Clinical Research, Brisbane, Australia. He has more than 650 peer-reviewed publications, including in journals such as NEJM, JAMA and Lancet. His major research interest is in clinical trials, and he was the leader of the MERINO trial of antibiotic options for ESBL producers.